KEMIRA Stock Analysis: Kemira | HE
Chemicals | HE, Finland | Market Cap: 2.371m EUR | 12M Return: -10.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.13M
EPS Trend: -98.3%
Qual. Beats: 1
Rev. Trend: -96.9%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Kemira Oyj is a Finnish specialty chemicals company operating across Europe, the Middle East, Africa, the Americas, and Asia Pacific. It is organized into three segments: Water Solutions, Packaging & Hygiene Solutions, and Fiber Essentials. The business is built on a B2B industrial chemicals model, serving municipalities and water-intensive industries with water treatment chemicals, supporting packaging, board, and tissue producers with process and functional chemicals, and supplying pulping and bleaching chemicals to pulp manufacturers. As a GICS Materials / Diversified Chemicals company, Kemiras revenues are tied to industrial production cycles, municipal water infrastructure spending, and consumption-linked end markets such as tissue, packaging, and pulp. Founded in 1920 and headquartered in Helsinki, the firm is listed on the Helsinki Stock Exchange and is classified as a mid-cap equity.
- EU water infrastructure capex lifts Water Solutions segment demand
- Tissue and packaging end-markets drive P&H Solutions revenue growth
- Energy and raw material cost volatility pressures segment margins
| Net Income: 148.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -0.44 > 1.0 |
| NWC/Revenue: 8.54% < 20% (prev 16.79%; Δ -8.25% < -1%) |
| CFO/TA 0.13 > 3% & CFO 410.3m > Net Income 148.0m |
| Net Debt (757.2m) to EBITDA (432.7m): 1.75 < 3 |
| Current Ratio: 1.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (160.9m) vs 12m ago 3.59% < -2% |
| Gross Margin: 18.43% > 18% (prev 17.58%; Δ 0.85% > 0.5%) |
| Asset Turnover: 87.13% > 50% (prev 91.93%; Δ -4.80% > 0%) |
| Interest Coverage Ratio: 8.93 > 6 (EBIT TTM 232.3m / Interest Expense TTM 26.0m) |
| A: 0.07 (Total Current Assets 949.3m - Total Current Liabilities 716.8m) / Total Assets 3.14b |
| B: 0.31 (Retained Earnings 981.8m / Total Assets 3.14b) |
| C: 0.07 (EBIT TTM 232.3m / Avg Total Assets 3.12b) |
| D: 1.01 (Book Value of Equity 1.57b / Total Liabilities 1.55b) |
| Altman-Z'' = 3.07 = A |
| DSRI: 1.03 (Receivables 448.7m/457.1m, Revenue 2.72b/2.85b) |
| GMI: 0.95 (GM 17.58% / 18.43%) |
| AQI: 1.11 (AQ_t 0.33 / AQ_t-1 0.30) |
| SGI: 0.95 (Revenue 2.72b / 2.85b) |
| TATA: -0.08 (NI 148.0m - CFO 410.3m) / TA 3.14b) |
| Beneish M = -3.02 (Cap -4..+1) = AA |
As of July 29, 2026, the stock is trading at EUR 16.48 with a total of 271,052 shares traded. Over the past week, the price has changed by -1.67%, over one month by +0.00%, over three months by -5.61% and over the past year by -10.55%.
Current recommended Stop Loss: 15.90 (which is 3.5% or 1.6 ATR below the current price).
Kemira has no consensus analysts rating.
P/E Trailing = 16.8866
P/E Forward = 13.4048
P/S = 0.8711
P/B = 1.4994
P/EG = 4.0157
Revenue TTM = 2.72b EUR
EBIT TTM = 232.3m EUR
EBITDA TTM = 432.7m EUR
Long Term Debt = 493.3m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 105.9m EUR (from shortTermDebt, last fiscal year)
Debt = 929.1m EUR (from shortLongTermDebtTotal, last fiscal year) + Leases 180.8m
Net Debt = 757.2m EUR (calculated: Debt 929.1m - CCE 171.9m)
Enterprise Value = 3.13b EUR (2.37b + Debt 929.1m - CCE 171.9m)
Interest Coverage Ratio = 8.93 (Ebit TTM 232.3m / Interest Expense TTM 26.0m)
EV/FCF = 15.06x (Enterprise Value 3.13b / FCF TTM 207.8m)
FCF Yield = 6.64% (FCF TTM 207.8m / Enterprise Value 3.13b)
FCF Margin = 7.63% (FCF TTM 207.8m / Revenue TTM 2.72b)
Net Margin = 5.44% (Net Income TTM 148.0m / Revenue TTM 2.72b)
Gross Margin = 18.43% ((Revenue TTM 2.72b - Cost of Revenue TTM 2.22b) / Revenue TTM)
Gross Margin QoQ = none% (prev 17.27%)
Tobins Q-Ratio = 1.00 (Enterprise Value 3.13b / Total Assets 3.14b)
Interest Expense / Debt = 2.80% (Interest Expense 26.0m / Debt 929.1m)
Taxrate = 22.71% (46.3m / 203.9m)
NOPAT = 179.6m (EBIT 232.3m * (1 - 22.71%))
Current Ratio = 1.32 (Total Current Assets 949.3m / Total Current Liabilities 716.8m)
Debt / Equity = 0.59 (Debt 929.1m / totalStockholderEquity, last quarter 1.57b)
Debt / EBITDA = 1.75 (Net Debt 757.2m / EBITDA 432.7m)
Debt / FCF = 3.64 (Net Debt 757.2m / FCF TTM 207.8m)
Total Stockholder Equity = 1.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.74% (Net Income 148.0m / Total Assets 3.14b)
RoE = 9.03% (Net Income TTM 148.0m / Total Stockholder Equity 1.64b)
RoCE = 10.89% (EBIT 232.3m / Capital Employed (Equity 1.64b + L.T.Debt 493.3m))
RoIC = 7.49% (NOPAT 179.6m / Invested Capital 2.40b)
WACC = 5.71% (E(2.37b)/V(3.30b) * Re(7.10%) + D(929.1m)/V(3.30b) * Rd(2.80%) * (1-Tc(0.23)))
Discount Rate = 7.10% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -0.58 | Cagr: 1.98%
[DCF] Terminal Value 74.73% ; FCFF base≈212.2m ; Y1≈204.1m ; Y5≈198.2m
[DCF] Fair Price = 16.27 (EV 3.11b - Net Debt 757.2m = Equity 2.36b / Shares 144.8m; r=8.35% [WACC [floored]]; 5y FCF grow -5.07% → 2.50% )
EPS Correlation: -98.25 | EPS CAGR: -17.73% | SUE: 0.92 | # QB: 1
Revenue Correlation: -96.90 | Revenue CAGR: -9.00% | SUE: -0.53 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.30 | Chg30d=-1.61% | Revisions=-40% | Analysts=2
EPS current Year (2026-12-31): EPS=1.13 | Chg30d=-0.48% | Revisions=-57% | GrowthEPS=-21.0% | GrowthRev=+2.0%
EPS next Year (2027-12-31): EPS=1.41 | Chg30d=-7.67% | Revisions=-57% | GrowthEPS=+24.4% | GrowthRev=+4.6%
[Analyst] Revisions Ratio: -77% (up=0, down=10)